TECHNOLOGY

All-ScaleFlow™

The world’s first All-Scale-in-One mRNA manufacturing solution.

Dillico’s game-changing All-ScaleFlow™ (ASF ®) technology offers an entirely new approach that enables the end-to-end production of mRNA-LNP, from In-Vitro Transcription to LNP encapsulation.

Production of mRNA-LNP at any scale. Using the same equipment and process design space.

Unique advantages of our mRNA-LNP manufacturing technology

Our continuous All-ScaleFlow™ technology enables the production of GMP-grade mRNA-LNP, with volumes per batch ranging from 1,000 doses for pre-clinical / phase 1 to 10 million doses for commercial production in three days, all using the same equipment and process design space.

All-ScaleFlow™ technology holds a number of advantages over existing approaches, making it both unique and competitive.

	Batch skid train	Batch integrated solution	Continuous micro-fluidic solution
Confined flow
Small scale down to 1,000 doses
Large scale up to 10m doses
Direct Scale-Up
Customizable process
Digital Twin	Difficult	Difficult	Possible

SOLUTION